Stocks
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EV/EBITDA | ? | 10.0 | -50.3 | 34.6 | 2.57 | -2.12 | -1.09 | |
| Changes by years, y/y, % | -4% | -602% | -169% | -93% | -182% | |||
Vanda Pharmaceuticals. EV/EBITDA
Vanda Pharmaceuticals. EV/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -0.11 | -2.21 | -1.63 | -1.27 | -1.33 | -1.09 | |
| Changes by years, y/y, % | -104% | -186% | -252% | -390% | -405% | |||
| Changes by quarters, q/q, % | -125% | +1 888% | -26% | -22% | +5% | |||
